Literature DB >> 26616887

Guillain Barré syndrome (GBS): new insights in the molecular mimicry between C. jejuni and human peripheral nerve (HPN) proteins.

Aida Loshaj-Shala1, Luca Regazzoni2, Armond Daci3, Marica Orioli2, Katerina Brezovska4, Ana Poceva Panovska4, Giangiacomo Beretta5, Ljubica Suturkova4.   

Abstract

Profile and immunoreactivity of proteins from HPN tissue, and from Campylobacter jejuni (O:19) were investigated. Proteins were extracted, separated by SDS-PAGE, their cross reactivity monitored by Western blotting, and identified by nHPLC-nESI-HRMS analysis. Proteins from C. jejuni, at Mw ~70 KDa were chaperone/co-chaperone proteins (GroEL, DnaK and HtpG). In the corresponding HPN band were serum albumin, neurofilament light peptide, cytoskeletal keratins and one HSP 70 and one HSP60. These chaperones reciprocally share high primary sequence homology and conservation of their known epitopes. These findings suggest that HSP chaperones may be suitable candidates involved in the molecular mimicry triggering GBS.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Campylobacter jejuni; Guillain–Barré syndrome; HPLC-HR-MS/MS; Heat shock proteins; Proteomics

Mesh:

Substances:

Year:  2015        PMID: 26616887     DOI: 10.1016/j.jneuroim.2015.11.005

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

Review 1.  The Burden of Enteropathy and "Subclinical" Infections.

Authors:  Elizabeth T Rogawski; Richard L Guerrant
Journal:  Pediatr Clin North Am       Date:  2017-08       Impact factor: 3.278

2.  Prevalence and antibiotic resistance of Campylobacter coli isolated from broiler farms in the Marrakesh Safi region, Morocco.

Authors:  Raja Asmai; Bouchra Karraouan; Khadija Es-Soucratti; Houda En-Nassiri; Brahim Bouchrif; Hakim Karib; Réda Triqui
Journal:  Vet World       Date:  2020-09-16

Review 3.  Axonal variants of Guillain-Barré syndrome: an update.

Authors:  Pei Shang; Mingqin Zhu; Ying Wang; Xiangyu Zheng; Xiujuan Wu; Jie Zhu; Jiachun Feng; Hong-Liang Zhang
Journal:  J Neurol       Date:  2020-03-05       Impact factor: 4.849

Review 4.  Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain-Barré Syndrome: Systematic Review.

Authors:  Fabienne Krauer; Maurane Riesen; Ludovic Reveiz; Olufemi T Oladapo; Ruth Martínez-Vega; Teegwendé V Porgo; Anina Haefliger; Nathalie J Broutet; Nicola Low
Journal:  PLoS Med       Date:  2017-01-03       Impact factor: 11.069

5.  Quantitative proteomics reveals Piccolo as a candidate serological correlate of recovery from Guillain-Barré syndrome.

Authors:  Lourdes Mateos-Hernández; Margarita Villar; Ernesto Doncel-Pérez; Marco Trevisan-Herraz; Ángel García-Forcada; Francisco Romero Ganuza; Jesús Vázquez; José de la Fuente
Journal:  Oncotarget       Date:  2016-11-15

6.  Prevalence, antimicrobial resistance and genetic diversity of Campylobacter coli and Campylobacter jejuni in Ecuadorian broilers at slaughter age.

Authors:  Christian Vinueza-Burgos; Magali Wautier; Delphine Martiny; Marco Cisneros; Inge Van Damme; Lieven De Zutter
Journal:  Poult Sci       Date:  2017-07-01       Impact factor: 3.352

Review 7.  Human campylobacteriosis: A public health concern of global importance.

Authors:  Aboi Igwaran; Anthony Ifeanyi Okoh
Journal:  Heliyon       Date:  2019-11-14

Review 8.  SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.

Authors:  Shahrzad Shoraka; Maria Lucia Brito Ferreira; Seyed Reza Mohebbi; Amir Ghaemi
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

Review 9.  Could Proteomics Become a Future Useful Tool to Shed Light on the Mechanisms of Rare Neurodegenerative Disorders?

Authors:  Maddalena Cagnone; Anna Bardoni; Paolo Iadarola; Simona Viglio
Journal:  High Throughput       Date:  2018-01-10

Review 10.  The Functions and Therapeutic Potential of Heat Shock Proteins in Inflammatory Bowel Disease-An Update.

Authors:  Abdullah Hoter; Hassan Y Naim
Journal:  Int J Mol Sci       Date:  2019-10-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.